According to the Minister of Industry and Trade of the Russian Federation, Denis Manturov, several Russian pharmaceutical companies are exploring the idea of establishing production facilities in the United Arab Emirates (UAE). This initiative specifically targets the localization of bioengineered drug production, including monoclonal antibodies.
He clarified that Russian companies are already developing the UAE market. The other day he discussed issues of industrial cooperation with the UAE Minister of Industry and Advanced Technologies Sultan bin Ahmed al-Jaber. They also talked about the development of the pharmaceutical sector.